Phase 1 trial evaluating safety, efficacy, and PK of AMG 510, a novel KRASG12C inhibitor, in non-small cell lung cancer Meeting Abstract


Authors: Govindan, R.; Fakih, M. G.; Price, T. J.; Falchook, G. S.; Desai, J.; Kuo, J. C.; Strickler, J. H.; Krauss, J. C.; Li, B. T.; Denlinger, C. S.; Durm, G.; Ngang, J.; Henary, H.; Ngarmchamnanrith, G.; Rasmussen, E.; Morrow, P. K.; Hong, D. S.
Abstract Title: Phase 1 trial evaluating safety, efficacy, and PK of AMG 510, a novel KRASG12C inhibitor, in non-small cell lung cancer
Meeting Title: 2019 Latin America Conference on Lung Cancer
Journal Title: Journal of Thoracic Oncology
Volume: 14
Issue: 11 Suppl. 2
Meeting Dates: 2019 Oct 17-19
Meeting Location: Mexico City, Mexico
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2019-11-01
Start Page: S1191
End Page: S1192
Language: English
ACCESSION: WOS:000494945000090
DOI: 10.1016/j.jtho.2019.09.181
PROVIDER: wos
Notes: Meeting Abstract: P2.15-C -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bob Tingkan Li
    278 Li